Matches in Nanopublications for { ?s ?p "[EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_assertion description "[EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- NP158422.RAvbKNqeYPBhHzv_i_BYk1FIt1rguT5mpoIJZd1Ux-T7s130_assertion description "[EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158422.RAvbKNqeYPBhHzv_i_BYk1FIt1rguT5mpoIJZd1Ux-T7s130_provenance.